glp-1/gip/glucagon triple agonist name Pharmacological options for weight management and people with T2D The Road towards Triple Agonists:
Description
With the rapid rise in demand, compounded medications have been developed that are more affordable, but can come with risks
GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial
Some patients were given CONTRAVE and others received a placebo (pill with no medication)
In a recent study, 92% of patients achieved their goals on the Programme alone
GLP-1 medications, peptides, NAD, and even exosome therapies have moved from niche clinical research into popular discussion
